peptuity.
WhatsApp

home / compounds / Triple Threat blend

Limited evidenceMetabolic & fat loss

Triple Threat blend

NAD+, MOTS-c and 5-Amino-1MQ combined. Three unproven items in one vial.

01

What it is

A vendor blend combining a coenzyme, a mitochondrial peptide and a small-molecule enzyme inhibitor.

02

What it does

Marketed around metabolic and energy claims drawn from each component’s proposed mechanism.

Does it work?

None of the three has strong controlled human evidence for these uses, and the combination has none at all. This is the least evidence-supported item in the chart.

03

Claims vs data

Each marketing claim, tagged by what the evidence actually supports.

Boosts energy and metabolismweak evidence
Each component is clinically provenoverreach
04

Reference figures

Quoted from published reference material. These are not Peptuity recommendations.

Vial100/10/10 mg
Diluent2 ml
Listed dose10 mg + 1 mg + 1 mg
Units / 1 ml20

Open the calculator →

05

The evidence, counted

Live counts from Europe PMC and ClinicalTrials.gov.

Publications 739
Randomised trials 7
Clinical trials 2
Registered studies 5

739 publications indexed, but only 7 randomised controlled trials and 5 registered interventional studies. Human evidence exists but is thin.

query: "MOTS-c" · checked 2026-08-07

Most-cited literature

Regulatory status

Formal, dated regulatory actions.

WADA — Prohibited List 2026

Blend of components that are individually prohibited in sport (WADA)

source →

06

Common questions

What are the three components?

NAD+ (a coenzyme), MOTS-c (a mitochondrial peptide) and 5-Amino-1MQ (a small-molecule enzyme inhibitor) — three different molecule classes in one vial.

Why do you call it the least-evidenced item?

None of the three has strong controlled human evidence for these uses, and the combination has none at all. Multiplying weak evidence does not add up to strong evidence.

Is the energy claim measurable?

Subjective energy is the easiest outcome to feel and the hardest to attribute. Without controlled comparison, reports of feeling better cannot be assigned to the vial.

07

Related compounds

Research use only

All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.

Ask a question